| IPO Company Profile |
| SEC Filings | Peer IPO Companies |
| Intracel Corporation |
| 2005 NW Sammamish Road, Suite 107, Issaquah, WA 98027 * (425) 392-2992 |
| The company is an integrated biopharmaceutical company focused on the development and commercialization of cancer vaccines and immunotherapeutic and diagnostic products for cancers and infectious diseases. |
| Manager | Tier | Phone |
| Donaldson, Lufkin & Jenrette Securities Corp. | Lead Manager | (212) 371-0641 |
| Nationsbanc Montgomery Securities, Inc. | Co-manager | (415) 627-2100 |
| NASNTL: | ICEL | Manufacturing: | SIC 2834 | |
| Type of Shares: | Common Shares | Filing Date: | 7/9/98 | |
| U.S. Shares Filed: | 4,000,000 | Filing Range: | $12.00 - $14.00 | |
| Non-U.S. Shares Filed: | 0 | Offering Amount: | $52,000,000 | |
| Primary Shares: | 4,000,000 | Expenses: | - | |
| Secondary Shares: | 0 | Post-IPO Shares: | 15,400,000 | |
| Employees: | 240 |
| Issuer's Law Firm: | Morrison & Foerster |
| Bank's Law Firm: | Brown & Wood |
| Auditor: | Pricewaterhouse Coopers LLC |
Dollar amounts in U.S. millions except for per share data | |||||
| 3 Month Ending Financials | |||||
| Full Year Audited Income | Latest Unaudited Income | Prior Audited Income | Balance Sheet | ||
| 12/31/97 | 3/31/98 | 3/31/97 | 3/31/98 | ||
| Revenue: | $13.45 | $5.46 | $3.79 | Assets: | $45.65 |
| Net Income: | -$8.48 | -$42.59 | -$1.73 | Curr Assets: | $8.69 |
| EPS: | Liabilities: | $41.57 | |||
| Prior EPS: | Curr Liab: | $12.87 | |||
| Cash Flow/Oper: | -$2.51 | -$2.96 | -$1.19 | Equity: | $4.07 |
| Cash Flow/Fin: | $5.52 | -$0.05 | $1.56 | Cash: | $0.73 |
| Cash Flow/Inv: | -$4.18 | $1.77 | -$0.68 | Working Cap: | -$4.18 |
| Use of Proceeds |
| The proceeds from the proposed offering will be used to support the establishment and early operation of oncoVAX Centers, to repay existing indebtedness, and for research and development, to conduct clinical trials for the company's cancer and infectious disease products and for working capital and general corporate purposes. |